Advanced Biomed Inc. Overview
Industry: Medical Specialities
Sector: Health Care
Advanced Biomed Inc. is a Nevada corporation specializing in innovative biomedical technologies for cancer detection and precision medicine. Operating through the subsidiary in Taiwan, the Company has developed a proprietary microfluidic platform that integrates semiconductor and biotechnology to enable advanced circulating tumor cell (CTC) detection, enrichment, and analysis. Its portfolio includes devices, biochips, and designed for cancer screening, diagnosis, treatment selection, and prognosis assessment, with regulatory clearances in progress in Taiwan and plans for future global expansion. Advanced Biomed Inc. is a Nevada corporation specializing in innovative biomedical technologies for cancer detection and precision medicine. Operating through the subsidiary in Taiwan, the Company has developed a proprietary microfluidic platform that integrates semiconductor and biotechnology to en
Verified company profile, price history, and SEC registration source are available.
10-Q/10-K financial data, or the foreign-issuer equivalent, is not available yet.
Review the SEC registration filingResearch snapshot
This Mavefund research page organizes verified information for Advanced Biomed Inc. (ADVB), including the company profile, price history, source-linked filings, available financial statements, research signals, and risks to review.
- Listing
- ADVB · Nasdaq · MIC XNAS
- Country
- United States
- Trading currency
- USD
- Industry
- Medical Specialities
Coverage is refreshed automatically and published only after data-integrity validation. Research support only; not personalized financial advice.
Reported Results
No latest earnings report cached yet
The latest source-linked annual or interim company filing has not been cached for this ticker yet.
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
No qualified company news in the last 14 days
No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.
Financial Statements
Company-reported filing facts, organized and linked to the original source.
Source details load with the filing data. Values are standardized company disclosures for research support, not personalized financial advice.